Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- 1 January 2016
- journal article
- case report
- Published by Elsevier in Cytotherapy
- Vol. 18 (1) , 80-90
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (23591627, 26461700)
- Ministry of Health, Labour and Welfare (H25-Soyaku-Shitei-007)
This publication has 41 references indexed in Scilit:
- NK cell-based immunotherapy for malignant diseasesCellular & Molecular Immunology, 2013
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and InhibitionAnnual Review of Immunology, 2013
- Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational useTherapeutic Advances in Hematology, 2012
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer CellsPLOS ONE, 2012
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor RegressionClinical Cancer Research, 2011
- Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutationsImmunology, 2011
- Identification and Metastatic Potential of Tumor-Initiating Cells in Malignant Rhabdoid Tumor of the KidneyClinical Cancer Research, 2009
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cellsCytotherapy, 2009
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001